z-logo
open-access-imgOpen Access
Gemcitabine plus Bevacizumab no better than Gemcitabine alone in Clinical Study of 600 Patients with Pancreatic Cancer
Publication year - 2007
Publication title -
cancer biology and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.166
H-Index - 113
eISSN - 1555-8576
pISSN - 1538-4047
DOI - 10.4161/cbt.6.2.3948
Subject(s) - gemcitabine , medicine , pancreatic cancer , bevacizumab , cancer , oncology , clinical trial , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom